ArticleCancer research2011

CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

Elda Righi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.